Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression

✍ Scribed by I. Zinonos; A. Labrinidis; V. Liapis; S. Hay; M. Lee; V. Ponomarev; P. Diamond; A.C.W. Zannettino; D.M. Findlay; A. Evdokiou

• Book ID: 116321523
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 62 KB
• Volume: 44
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2009.01.463